ArticleDie Naturwissenschaften2026
Analysis of GyrA gene mutations in environmental Escherichia coli: understanding the mechanisms and spread of quinolone resistance in ecosystems.
Article in Die Naturwissenschaften, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The spread of antimicrobial resistance to antibiotics has emerged as a global health threat to contemporary medical practice. Among the various antibiotic-resistant pathogens of concern, fluoroquinolone-resistant Escherichia coli has been increasingly detected in environmental reservoirs. The present study investigates the molecular screening of the gyrA gene in E. coli isolates derived from various environmental sources, focusing on the identification and genetic analysis of mutations in the Quinolone Resistance-Determining Region. In this study, antimicrobial susceptibility testing was initially performed on 50 non-duplicate E. coli isolates collected during the study period. Among these, only 10 isolates exhibited phenotypic resistance to the antibiotics of interest, while the remaining 40 were fully susceptible. Because the primary objective of the work was to characterize resistant strains in detail, subsequent analyses were restricted to these 10 resistant isolates, which explains the final sample size presented for resistance-related results. DNA was extracted and was confirmed by 16 S rRNA gene sequencing. The gyrA gene was amplified and sequenced to detect mutations associated with quinolone resistance. About 8 specific mutations were identified in most of the samples and correlated with the quinolone susceptibility profiles of each isolate, which were determined using Kirby bauer disk diffusion method for a range of antibiotics. Our results revealed a significant prevalence of QRDR mutations, especially at the 248th (Ser-83) and 259th (Asp-87) positions in gyrA gene, which were strongly associated with increased resistance to quinolones. These findings highlight the need for vigilant use of fluoroquinolones to mitigate the spread of microbial resistance.
Indexed as
Identifiers
41697354What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.